Nov 13, 2022
Walvax and Etana Sign MOU for PCV and HPV Production Collaboration in Indonesia
Learn More
Oct 21, 2022
Walvax’s Management Member Elected to DCVMN Board
Learn More
Sep 30, 2022
Walvax and Abogen Granted Indonesian Emergency Use Authorization for the SARS-CoV-2 mRNA Vaccine (AWcorna)
Learn More
May 21, 2022
Walvax Shipped the First Batch of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine to the Kingdom of Morocco
Learn More
May 13, 2022
Walvax announces the receipt of the purchase order from Morocco for the 13-valent pneumococcal polysaccharide conjugate vaccine
Learn More
May 11, 2022
Walvax Publishes Immunogenicity and Safety Data from Phase 3 Clinical Study of PCV13 (the 2nd available 13-valent pneumococcal polysaccharide conjugate vaccine worldwide) in Frontiers in Microbiology
Learn More
Feb 8, 2022
CEPI, Shanghai Zerun Biotech and Walvax Biotech expand collaboration to develop COVID-19 multi-variant vaccine
Learn More
Feb 7, 2022
Walvax and Abogen Announce Safety and Immunogenicity Data from Phase 1 Clinical Study of AWcorna (SARS-CoV-2 mRNA Vaccine) Published in The Lancet Microbe
Learn More
Media Contact
Media Team
media@walvax.com
